Clinical Trials · NCT03553602
HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer
- Phase
- Phase 1/Phase 2
- Recruitment status
- Terminated
- Sponsor
- Loyola University
- Enrollment
- 3
- Start date
- Dec 2017
- Locations
- 1 site, United States
- Primary endpoint
- Genitourinary Toxicity